Evidence map›Paper›PMID 38756066›Full record

ArticleClinical endoscopy2024

Prophylactic endoscopic transpapillary gallbladder stenting to prevent acute cholecystitis induced after metallic stent placement for malignant biliary strictures: a retrospective study in Japan.

Fumisato Kozakai, Yoshihide Kanno, Shinsuke Koshita, Takahisa Ogawa, Hiroaki Kusunose, Toshitaka Sakai, Keisuke Yonamine, Kazuaki Miyamoto, Haruka Okano, Yuto Matsuoka and 3 more

Abstract read
In one paragraph

Article in Clinical endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fumisato KozakaiDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Yoshihide KannoDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Shinsuke KoshitaDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Takahisa OgawaDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Hiroaki KusunoseDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Toshitaka SakaiDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Keisuke YonamineDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Kazuaki MiyamotoDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Haruka OkanoDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Yuto MatsuokaDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Kento HosokawaDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Hidehito SumiyaDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.
Kei ItoDepartment of Gastroenterology, Sendai City Medical Center, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsEndoscopic biliary drainage using self-expandable metallic stents (SEMSs) for malignant biliary strictures occasionally induces acute cholecystitis (AC). This study evaluated the efficacy of prophylactic gallbladder stents (GBS) during SEMS placement.

methodsAmong 158 patients who underwent SEMS placement for malignant biliary strictures between January 2018 and March 2023, 30 patients who attempted to undergo prophylactic GBS placement before SEMS placement were included.

resultsTechnical success was achieved in 21 cases (70.0%). The mean diameter of the cystic duct was more significant in the successful cases (6.5 mm vs. 3.7 mm, p<0.05). Adverse events occurred for 7 patients (23.3%: acute pancreatitis in 7; non-obstructive cholangitis in 1; perforation of the cystic duct in 1 with an overlap), all of which improved with conservative treatment. No patients developed AC when the GBS placement was successful, whereas 25 of the 128 patients (19.5%) without a prophylactic GBS developed AC during the median follow-up period of 357 days (p=0.043). In the multivariable analysis, GBS placement was a significant factor in preventing AC (hazard ratio, 0.61; 95% confidence interval, 0.37-0.99; p=0.045).

conclusionsGBS may contribute to the prevention of AC after SEMS placement for malignant biliary strictures.

Indexed as

CholecystitisEndoscopic biliary drainageGallbladderNeoplasmsSelf expandable metallic stents

Identifiers

PMID38756066
PMCPMC11474467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.